Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2539PDF: 1966HTML: 1098 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3129PDF: 1491HTML: 3750Untitled: 286Untitled: 282Untitled: 235 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
992PDF: 195HTML: 239 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
657PDF: 329HTML: 169 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1476PDF: 1178HTML: 283 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1277PDF: 1272Suppl. Files: 614HTML: 117 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1793HTML: 733PDF: 951 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
4054PDF: 1812HTML: 11994Figures Haase: 325 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3609PDF: 2141HTML: 7598 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2175PDF: 879HTML: 740Table1: patient's characteristics: 275Table 2: profile of each patient: 262 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2675HTML: 375PDF: 999 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
4016PDF: 1363HTML: 5109Incidence age-standardized rates for HL across the Mediterranean basin: 281 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3477PDF: 1825HTML: 1198 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2792PDF: 910HTML: 5411 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9668PDF: 6383HTML: 88350Fig.1b: 319Fig.1c: 328Fig.2a: 325Fig.2b: 287Fig.4: 355Fig.2c: 306Fig.3: 303Tab.1: 367Tab.2: 337Tab.3: 328Tab.4: 380Fig1a: 320 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1823PDF: 1184HTML: 532 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3903PDF: 2691HTML: 1732 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3922PDF: 1012HTML: 6899 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
3421PDF: 1156HTML: 359Suppl. Files: 550 -
SOLITARY PLASMACYTOMA
4463PDF: 2327HTML: 1457fIGURES 1,2: 300 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2398PDF: 1755HTML: 754 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3352PDF: 984HTML: 7329Kost Fig1: 252Kost Fig 2: 231Kost Fig3: 252Kost Fig 4: 268Kost Fig5: 255Kost fig 6: 251 -
-
TYROSINE KINASE INHIBITORS AND PREGNANCY
3945PDF: 1838HTML: 2786 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2693PDF: 895HTML: 1770 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4267PDF: 1686HTML: 9336Untitled: 368Untitled: 241Untitled: 230Untitled: 248Untitled: 241Untitled: 411 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
3007PDF: 1302HTML: 3340 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4179PDF: 1158HTML: 3931Untitled: 215Cneo. Fig.1: 150Untitled: 144Untitled: 183Untitled: 188 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3153PDF: 1129HTML: 5689







